Alternatively, cardioprotection by IL-22 may be exerted by the maintenance of tissue homeostasis before MI, as discussed above, through the IL-22R1/IL-10RB expression at low levels in non-immune cells. The gene discussed is IL22RA1; the disease is myocardial infarction.